SCHEMBL25465685

SCHEMBL25465685

c1ccc(-c2c3ccccc3c(-c3ccc4oc(-c5cc6ccccc6c6ccccc56)cc4c3)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
RAB9A P51151 2/20 0.42
PTGES O14684 1/20 0.41
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
PLG P00747 1/20 0.41
PLAU P00749 1/20 0.41
PLAT P00750 1/20 0.41
PRSS1 P07477 1/20 0.41
GPR84 Q9NQS5 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
AHR P35869 1/20 0.40
PAX8 Q06710 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CHRM2 P08172 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25022558 0.92 GPR84 (0.42) MAOBKMT2AMEN1RAB9AGPR84
SCHEMBL25466555 0.87 MAOB (0.38) MAOBKMT2AMEN1RAB9APTGES
SCHEMBL25465695 0.86 F2 (0.49) MAOBKMT2AMEN1RAB9AF2
SCHEMBL29315831 0.86 MAOB (0.50) MAOBKMT2AMEN1RAB9APTGES
SCHEMBL25465699 0.86 F2 (0.48) MAOBKMT2AMEN1RAB9AF2
SCHEMBL29598277 0.85 MAOB (0.58) MAOBRAB9APTGESCYP1A1CYP1A2
SCHEMBL22954091 0.85 MAOB (0.58) MAOBRAB9APTGESCYP1A1CYP1A2
SCHEMBL25465700 0.84 MAOB (0.57) MAOBRAB9APTGESCYP1A1CYP1A2
SCHEMBL25056588 0.82 MAOB (0.55) MAOBRAB9APTGESCYP1A1CYP1A2
SCHEMBL25465740 0.81 MAOB (0.57) MAOBRAB9APTGESCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY2, TRPA1, ANXA1 MAOB 591/4885KMT2A 949/4885MEN1 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.